nach oben

Journal of Diabetes & Metabolic Disorders

Erschienen in:

07.01.2021 | Review article

Effects of propolis supplementation on glycemic status, lipid profiles, inflammation and oxidative stress, liver enzymes, and body weight: a systematic review and meta-analysis of randomized controlled clinical trials

verfasst von: Jamal Hallajzadeh, Alireza Milajerdi, Elaheh Amirani, Vahideh Ebrahimzadeh Attari, Hossein Maghsoudi, Seyyed Mehdi Mirhashemi

Erschienen in: Journal of Diabetes & Metabolic Disorders | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Abstract

The aim of meta-analysis was to assess the effects of propolis on markers of oxidative stress, lipid profiles, inflammation and glycemic control, liver enzymes, and weight control. The heterogeneity between the included studies was indicated using the Cochrane’s Q test and I-square (I²) statistic. 14 trials were included in this meta-analysis. Our meta-analysis indicated a significant reduction in fating glucose (WMD: -17.00; 95% CI: −30.88, −3.11), HbA1C (WMD: -0.42; 95% CI: −0.75, −0.10), and insulin (WMD: -1.75; 95% CI: −3.24, −0.26) and a marginally significant reduction in insulin resistance (WMD: -0.60; 95% CI: −1.20, 0.00) following propolis supplementation in 10, 8, 6, and 5 studies, respectively. Pooling 5 effect sizes, a significant reduction was seen in ALT (WMD: -5.63; 95% CI: −10.59, −0.67) and aspartate aminotransferase (AST) (WMD: -3.09; 95% CI: −5.15, −1.03) following propolis. A significant beneficial effect was observed for CRP (WMD: -1.11; 95% CI: −1.92, −0.29), TNF-α (WMD: -6.71; 95% CI: −9.44, −3.98) and interleukin-6 (IL-6) (WMD: -17.99; 95% CI: −35.56, −0.42) concentrations after propolis supplementation. This study demonstrated the beneficial effects of propolis on FPG, HbA1c, insulin, CRP, TNF-α and liver enzymes levels.

Nur mit Berechtigung zugänglich

Toreti VC, Sato HH, Pastore GM, Park YK (2013) Recent progress of propolis for its biological and chemical compositions and its botanical origin. Evidence-based complementary and alternative medicine 2013.

Mizrahi A, Lensky Y (2013) Bee products: properties, applications, and apitherapy. Springer Science & Business Media,

Hausen B, Wollenweber E, Senff H, Post B. Propolis allergy.(II). The sensitizing properties of 1, 1-dimethylallyl caffeic acid ester. Contact Dermatitis. 1987;17(3):171–7.CrossRef

Kuropatnicki AK, Szliszka E, Krol W. Historical aspects of propolis research in modern times. Evidence-based complementary and alternative medicine : eCAM. 2013;2013:964149–11. https://doi.org/10.1155/2013/964149.CrossRef

Bueno-Silva B, Alencar SM, Koo H, Ikegaki M, Silva GV, Napimoga MH, et al. Anti-inflammatory and antimicrobial evaluation of neovestitol and vestitol isolated from Brazilian red propolis. J Agric Food Chem. 2013;61(19):4546–50.CrossRef

Martin LFT, Rocha EM, Garcia SB, Paula JS. Topical Brazilian propolis improves corneal wound healing and inflammation in rats following alkali burns. BMC Complement Altern Med. 2013;13(1):337.CrossRef

Asemi Z, Akbari M, Lankarani KB, Tabrizi R, Ghayour-Mobarhan M, Ferns G, et al. The effects of curcumin on weight loss among patients with metabolic syndrome and related disorders: a systematic review and meta-analysis of randomized controlled trials. Front Pharmacol. 2019;10:649.CrossRef

Verma MK, Pandey RK, Khanna R, Agarwal J. The antimicrobial effectiveness of 25% propolis extract in root canal irrigation of primary teeth. Journal of Indian Society of Pedodontics and Preventive Dentistry. 2014;32(2):120.CrossRef

Campos JF, dos Santos UP, Macorini LFB, de Melo AMMF, Balestieri JBP, Paredes-Gamero EJ, et al. Antimicrobial, antioxidant and cytotoxic activities of propolis from Melipona orbignyi (Hymenoptera, Apidae). Food Chem Toxicol. 2014;65:374–80.CrossRef

10.

Lopes AA, Ferreira TS, Nesi RT, Lanzetti M, Pires KMP, Silva AM, et al. Antioxidant action of propolis on mouse lungs exposed to short-term cigarette smoke. Bioorg Med Chem. 2013;21(24):7570–7.CrossRef

11.

Fuliang H, Hepburn H, Xuan H, Chen M, Daya S, Radloff S. Effects of propolis on blood glucose, blood lipid and free radicals in rats with diabetes mellitus. Pharmacol Res. 2005;51(2):147–52.CrossRef

12.

Shukla S, Bhadauria M, Jadon A. Evaluation of hepatoprotective potential of propolis extract in carbon tetrachloride induced liver injury in rats. Indian J Biochem Biophys. 2005;42(5):321–5.PubMed

13.

Babatunde IR, Abdulbasit A, Oladayo MI, Olasile OI, Olamide FR, Gbolahan BW. Hepatoprotective and pancreatoprotective properties of the ethanolic extract of Nigerian propolis. Journal of intercultural ethnopharmacology. 2015;4(2):102–8.CrossRef

14.

Omene C, Kalac M, Wu J, Marchi E, Frenkel K, O’Connor OA. Propolis and its active component, caffeic acid phenethyl ester (CAPE), modulate breast cancer therapeutic targets via an epigenetically mediated mechanism of action. Journal of cancer science & therapy. 2013;5(10):334–42.

15.

Nakajima Y, Shimazawa M, Mishima S, Hara H. Water extract of propolis and its main constituents, caffeoylquinic acid derivatives, exert neuroprotective effects via antioxidant actions. Life Sci. 2007;80(4):370–7.CrossRef

16.

Fan Y, Ma L, Zhang W, Wang J, Chen Y, Gao Y, et al. The design of propolis flavone microemulsion and its effect on enhancing the immunity and antioxidant activity in mice. Int J Biol Macromol. 2014;65:200–7.CrossRef

17.

Orsatti C, Missima F, Pagliarone A, Bachiega TF, Búfalo M, Araújo J Jr, et al. Propolis immunomodulatory action in vivo on toll-like receptors 2 and 4 expression and on pro-inflammatory cytokines production in mice. Phytother Res. 2010;24(8):1141–6.CrossRef

18.

Maruyama H, Sumitou Y, Sakamoto T, Araki Y, Hara H. Antihypertensive effects of flavonoids isolated from brazilian green propolis in spontaneously hypertensive rats. Biol Pharm Bull. 2009;32(7):1244–50.CrossRef

19.

Mishima S, Yoshida C, Akino S, Sakamoto T. Antihypertensive effects of Brazilian propolis: identification of caffeoylquinic acids as constituents involved in the hypotension in spontaneously hypertensive rats. Biol Pharm Bull. 2005;28(10):1909–14.CrossRef

20.

Karimian J, Hadi A, Pourmasoumi M, Najafgholizadeh A, Ghavami A. The efficacy of propolis on markers of glycemic control in adults with type 2 diabetes mellitus: a systematic review and meta-analysis. Phytotherapy research : PTR. 2019;33(6):1616–26. https://doi.org/10.1002/ptr.6356.CrossRefPubMed

21.

Silva-Carvalho R, Baltazar F, Almeida-Aguiar C. Propolis: a complex natural product with a plethora of biological activities that can be explored for drug development. Evidence-based complementary and alternative medicine : eCAM. 2015;2015:206439–29. https://doi.org/10.1155/2015/206439.CrossRef

22.

Turner RM, Davey J, Clarke MJ, Thompson SG, Higgins JP. Predicting the extent of heterogeneity in meta-analysis, using empirical data from the Cochrane database of systematic reviews. Int J Epidemiol. 2012;41(3):818–27. https://doi.org/10.1093/ije/dys041.CrossRefPubMedPubMedCentral

23.

Sterne JA, Egger M. Regression methods to detect publication and other bias in meta-analysis. Publication bias in meta-analysis: Prevention, assessment and adjustments. 2005:99–110.

24.

Salehi-Sahlabadi A, Chhabra M, Rahmani J, Momeni A, Karam G, Nattagh-Eshtivani E, Nouri M, Clark C, Salehi P, Hekmatdoost A (2020) The effect of propolis on anthropometric indices and lipid profile: a systematic review and meta-analysis of randomized controlled trials. Journal of Diabetes & Metabolic Disorders:1–9.

25.

Mujica V, Orrego R, Pérez J, Romero P, Ovalle P, Zúñiga-Hernández J, Arredondo M, Leiva E (2017) The role of propolis in oxidative stress and lipid metabolism: a randomized controlled trial. Evidence-Based Complementary and Alternative Medicine 2017.

26.

Zakerkish M, Jenabi M, Zaeemzadeh N, Hemmati AA, Neisi N. The effect of Iranian propolis on glucose metabolism, lipid profile, insulin resistance, renal function and inflammatory biomarkers in patients with type 2 diabetes mellitus: a randomized double-blind clinical trial. Sci Rep. 2019;9(1):1–11.CrossRef

27.

Afsharpour F, Hashemipour S, Khadem-Haghighian H, Koushan Y. Effects of Iranian propolis on glycemic status, inflammatory factors, and liver enzyme levels in type 2 diabetic patients: a randomized, double-blind, placebo-controlled, clinical trial. Journal of Nutritional Sciences and Dietetics. 2017:9–14.

28.

Gholaminejad F, Javadi M, Karami AA, Alizadeh F, Kavianpour M, Khadem Haghighian H. Propolis supplementation effects on semen parameters, oxidative stress, inflammatory biomarkers and reproductive hormones in infertile men with Asthenozoospermia; a randomized clinical trial. International Journal of Medical Laboratory. 2019;6(1):21–32.

29.

Samadi N, Mozaffari-Khosravi H, Rahmanian M, Askarishahi M. Effects of bee propolis supplementation on glycemic control, lipid profile and insulin resistance indices in patients with type 2 diabetes: a randomized, double-blind clinical trial. Journal of integrative medicine. 2017;15(2):124–34.CrossRef

30.

Koya-Miyata S, Arai N, Mizote A, Taniguchi Y, Ushio S, Iwaki K, et al. Propolis prevents diet-induced hyperlipidemia and mitigates weight gain in diet-induced obesity in mice. Biol Pharm Bull. 2009;32(12):2022–8.CrossRef

31.

Zhao L, Pu L, Wei J, Li J, Wu J, Xin Z, et al. Brazilian green Propolis improves antioxidant function in patients with type 2 diabetes mellitus. Int J Environ Res Public Health. 2016;13(5). https://doi.org/10.3390/ijerph13050498.

32.

Gao W, Pu L, Wei J, Yao Z, Wang Y, Shi T, et al. Serum antioxidant parameters are significantly increased in patients with type 2 diabetes mellitus after consumption of Chinese Propolis: a randomized controlled trial based on fasting serum glucose level. Diabetes therapy : research, treatment and education of diabetes and related disorders. 2018;9(1):101–11. https://doi.org/10.1007/s13300-017-0341-9.CrossRef

33.

Anderson RA. Chromium, glucose intolerance and diabetes. J Am Coll Nutr. 1998;17(6):548–55.CrossRef

34.

Ueda M, Hayashibara K, Ashida H. Propolis extract promotes translocation of glucose transporter 4 and glucose uptake through both PI3K-and AMPK-dependent pathways in skeletal muscle. Biofactors. 2013;39(4):457–66.CrossRef

35.

Kang LJ, Lee HB, Bae HJ, Lee SG. Antidiabetic effect of propolis: reduction of expression of glucose-6-phosphatase through inhibition of Y279 and Y216 autophosphorylation of GSK-3α/β in HepG2 cells. Phytother Res. 2010;24(10):1554–61.CrossRef

36.

Yu Y, Si Y, Song G, Luo T, Wang J, Qin S. Ethanolic extract of propolis promotes reverse cholesterol transport and the expression of ATP-binding cassette transporter A1 and G1 in mice. Lipids. 2011;46(9):805–11.CrossRef

37.

Iio A, Ohguchi K, Maruyama H, Tazawa S, Araki Y, Ichihara K, et al. Ethanolic extracts of Brazilian red propolis increase ABCA1 expression and promote cholesterol efflux from THP-1 macrophages. Phytomedicine. 2012;19(5):383–8.CrossRef

38.

Li Y, Chen M, Xuan H, Hu F (2012) Effects of encapsulated propolis on blood glycemic control, lipid metabolism, and insulin resistance in type 2 diabetes mellitus rats. Evid Based Complement Alternat Med

39.

Bahmani F, Tajadadi-Ebrahimi M, Kolahdooz F, Mazouchi M, Hadaegh H, Jamal AS, et al. The consumption of Synbiotic bread containing Lactobacillus sporogenes and inulin affects nitric oxide and malondialdehyde in patients with type 2 diabetes mellitus: randomized, double-blind, placebo-controlled trial. J Am Coll Nutr. 2016;35(6):506–13. https://doi.org/10.1080/07315724.2015.1032443.CrossRefPubMed

40.

Tajadadi-Ebrahimi M, Bahmani F, Shakeri H, Hadaegh H, Hijijafari M, Abedi F, et al. Effects of daily consumption of synbiotic bread on insulin metabolism and serum high-sensitivity C-reactive protein among diabetic patients: a double-blind, randomized, controlled clinical trial. Ann Nutr Metab. 2014;65(1):34–41. https://doi.org/10.1159/000365153.CrossRefPubMed

41.

Shang H, Bhagavathula AS, Aldhaleei WA, Rahmani J, Karam G, Rinaldi G, et al. Effect of propolis supplementation on C-reactive protein levels and other inflammatory factors: a systematic review and meta-analysis of randomized controlled trials. Journal of King Saud University-Science. 2020;32(2):1694–701.CrossRef

42.

Zhu A, Wu Z, Zhong X, Ni J, Li Y, Meng J, et al. Brazilian green Propolis prevents cognitive decline into mild cognitive impairment in elderly people living at high altitude. Journal of Alzheimer's disease : JAD. 2018;63(2):551–60. https://doi.org/10.3233/jad-170630.CrossRefPubMed

43.

Silveira MAD, Teles F, Berretta AA, Sanches TR, Rodrigues CE, Seguro AC, et al. Effects of Brazilian green propolis on proteinuria and renal function in patients with chronic kidney disease: a randomized, double-blind, placebo-controlled trial. BMC Nephrol. 2019;20(1):140. https://doi.org/10.1186/s12882-019-1337-7.CrossRefPubMed

44.

Mujica V, Orrego R, Perez J, Romero P, Ovalle P, Zuniga-Hernandez J, et al. The role of Propolis in oxidative stress and lipid metabolism: a randomized controlled trial. Evidence-based complementary and alternative medicine : eCAM. 2017;2017:4272940–11. https://doi.org/10.1155/2017/4272940.CrossRef

45.

Afsharpour F, Javadi M, Hashemipour S, Koushan Y, Haghighian HK. Propolis supplementation improves glycemic and antioxidant status in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled study. Complementary therapies in medicine. 2019;43:283–8. https://doi.org/10.1016/j.ctim.2019.03.001.CrossRefPubMed

46.

Tolba MF, Azab SS, Khalifa AE, Abdel-Rahman SZ, Abdel-Naim AB. Caffeic acid phenethyl ester, a promising component of propolis with a plethora of biological activities: a review on its anti-inflammatory, neuroprotective, hepatoprotective, and cardioprotective effects. IUBMB Life. 2013;65(8):699–709. https://doi.org/10.1002/iub.1189.CrossRefPubMed

47.

Kurek-Górecka A, Rzepecka-Stojko A, Górecki M, Stojko J, Sosada M, Swierczek-Zieba G. Structure and antioxidant activity of polyphenols derived from propolis. Molecules (Basel, Switzerland). 2013;19(1):78–101. https://doi.org/10.3390/molecules19010078.CrossRef

48.

Khayyal MT, el-Ghazaly MA, el-Khatib AS, Hatem AM, de Vries PJ, el-Shafei S, et al. A clinical pharmacological study of the potential beneficial effects of a propolis food product as an adjuvant in asthmatic patients. Fundam Clin Pharmacol. 2003;17(1):93–102. https://doi.org/10.1046/j.1472-8206.2003.00117.x.CrossRefPubMed

49.

Fukuda T, Fukui M, Tanaka M, Senmaru T, Iwase H, Yamazaki M, et al. Effect of Brazilian green propolis in patients with type 2 diabetes: a double-blind randomized placebo-controlled study. Biomedical reports. 2015;3(3):355–60. https://doi.org/10.3892/br.2015.436.CrossRefPubMedPubMedCentral

50.

El-Sharkawy HM, Anees MM, Van Dyke TE. Propolis improves periodontal status and glycemic control in patients with type 2 diabetes mellitus and chronic periodontitis: a randomized clinical trial. J Periodontol. 2016;87(12):1418–26. https://doi.org/10.1902/jop.2016.150694.CrossRefPubMed

51.

Afsharpour F, Hashemipour S, Khadem-Haghighian H, Koushan Y (2017) Effects of Iranian propolis on glucose metabolic changes, inflammatory factors, liver enzymes levels in type 2 diabetic patients: a randomized, double-blind, placebo-controlled, clinical trial. Journal of Nutritional Sciences and Dietetics.

52.

Zakerkish M, Jenabi M, Zaeemzadeh N, Hemmati AA, Neisi N. The effect of Iranian Propolis on glucose metabolism, lipid profile, insulin resistance, renal function and inflammatory biomarkers in patients with type 2 diabetes mellitus: a randomized double-blind clinical trial. Sci Rep. 2019;9(1):7289. https://doi.org/10.1038/s41598-019-43838-8.CrossRefPubMed

53.

Koo HJ, Lee KR, Kim HS, Lee BM. Detoxification effects of aloe polysaccharide and propolis on the urinary excretion of metabolites in smokers. Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association. 2019;130:99–108. https://doi.org/10.1016/j.fct.2019.05.029.CrossRef

Titel: Effects of propolis supplementation on glycemic status, lipid profiles, inflammation and oxidative stress, liver enzymes, and body weight: a systematic review and meta-analysis of randomized controlled clinical trials
verfasst von: Jamal Hallajzadeh
Alireza Milajerdi
Elaheh Amirani
Vahideh Ebrahimzadeh Attari
Hossein Maghsoudi
Seyyed Mehdi Mirhashemi
Publikationsdatum: 07.01.2021
Verlag: Springer International Publishing
Erschienen in: Journal of Diabetes & Metabolic Disorders / Ausgabe 1/2021
Elektronische ISSN: 2251-6581
DOI: https://doi.org/10.1007/s40200-020-00696-w

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2021

Association of a body shape index and hip index with cardiometabolic risk factors in children and adolescents: the CASPIAN-V study

Association between IL-18 and IL-6 gene polymorphisms and the risk of T1D in Egyptian children

Effects of Akkermansia muciniphila and Faecalibacterium prausnitzii on serotonin transporter expression in intestinal epithelial cells

Assessment of fecal Akkermansia muciniphila in patients with osteoporosis and osteopenia: a pilot study

Gene set enrichment analysis of PPAR-γ regulators from Murraya odorata Blanco